14-day Premium Trial Subscription Try For FreeTry Free

Personalis Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.02. In total, the insiders bought 13 591 575 and sold 152 332 PSNL shares in the last 100 trades.

Insider Power

(Last 100 transactions)
94.02
Buy 13 591 575 Shares
Sell 152 332 Shares

Historical Insider Trades

Date Type Action Person Amount
May 17, 2024 Stock Option (right to buy) Buy Myers Woodrow A Jr 50 000
May 17, 2024 Stock Option (right to buy) Buy Shoff Lonnie 50 000
May 17, 2024 Stock Option (right to buy) Buy Eastham Karin 50 000
May 17, 2024 Stock Option (right to buy) Buy Bowman A Blaine 50 000
May 17, 2024 Stock Option (right to buy) Buy Bloom Olivia Kyusuk 50 000
May 17, 2024 Common Stock Sell Chen Richard 940
May 17, 2024 Common Stock Sell Tachibana Aaron 1 333
May 17, 2024 Common Stock Sell Moore Stephen Michael 1 731
May 17, 2024 Stock Option (right to buy) Buy Widder Kenneth J 50 000
Apr 30, 2024 Common Stock Sell Moore Stephen Michael 4 523
Mar 15, 2024 Stock Option (right to buy) Buy Hall Christopher M 400 000
Mar 15, 2024 Stock Option (right to buy) Buy Chen Richard 175 000
Mar 15, 2024 Stock Option (right to buy) Buy Tachibana Aaron 175 000
Mar 15, 2024 Stock Option (right to buy) Buy Moore Stephen Michael 100 000
Mar 01, 2024 Common Stock Buy Myers Woodrow A Jr 10 000
Jan 29, 2024 Common Stock Sell Chen Richard 526
Jan 29, 2024 Common Stock Sell Tachibana Aaron 716
Dec 15, 2023 Common Stock Sell Chen Richard 4 708
Dec 15, 2023 Common Stock Sell Tachibana Aaron 6 747
Dec 15, 2023 Common Stock Sell Moore Stephen Michael 1 476
Nov 28, 2023 Warrant (Right to Buy) Buy Tempus Labs, Inc. 4 609 400
Nov 28, 2023 Warrant (Right to Buy) Buy Tempus Labs, Inc. 4 609 400
Nov 16, 2023 Common Stock Sell Moore Stephen Michael 1 722
Nov 16, 2023 Common Stock Sell Tachibana Aaron 1 344
Nov 16, 2023 Common Stock Sell Chen Richard 940
Click to get the best stock tips daily for free!

About Personalis Inc.

Personalis. Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from ... PSNL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT